Literature DB >> 22446985

MR, CT, and PET imaging in pericardial disease.

Peter Alter1, Jens H Figiel, Thomas P Rupp, Georg F Bachmann, Bernhard Maisch, Marga B Rominger.   

Abstract

Although echocardiography remains the standard diagnostic tool for identifying pericardial diseases, procedures with better delineation of morphology and heart function are often required. The pericardium consists of an inner visceral (epicardium) and outer parietal layer (pericardium), which constitute for the pericardial cavity. Pericardial effusion can occur as transudate, exudate, pyopneumopericardium, or hemopericardium. Potential causes are inflammatory processes, that is, pericarditis due to autoimmune or infective reasons, neoplasms, irradiation, or systemic disorders, chronic renal failure, endocrine, or metabolic diseases. Pericardial fat can mimic pericardial effusion. Using various image-acquisition sequences, MRI allows identifying and separating fluid and solid structures. Fast spin-echo T1-weighted sequences with black-blood preparation are favourably used for morphological evaluation. Fast spin-echo T2-weighted sequences, particularly with fat saturation, and short-tau inversion-recovery sequences are useful to visualize oedema and inflammation. For further tissue characterization, delayed inversion-recovery imaging is used. Therefore, image acquisition is performed at 5-20 min subsequent to contrast agent administration, the so-called technique of late gadolinium enhancement. Ventricular volumes and myocardial mass can be assessed accurately by steady-state free-precession sequences, which is required to measure cardiac function and ventricular wall stress. Constrictive pericarditis usually results from chronic inflammatory processes leading to increased stiffness, which impedes the slippage of both pericardial layers and thereby the normal cardiac filling. CT imaging can favourably assess pericardial calcification. Thus, MR and CT imaging allow a comprehensive delineation of the pericardium. Superior to echocardiography, both methods provide a larger field of view and depiction of the complete chest including abnormalities of the surrounding mediastinum and lungs. PET provides unique information on the in vivo metabolism of 18-fluorodeoxyglucose that can be superimposed on CT findings and is useful for identifying inflammatory processes or masses, for example neoplasms. These imaging techniques provide advanced information of anatomy and cardiac function to optimize the pericardial access, for example by the AttachLifter system, for diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22446985     DOI: 10.1007/s10741-012-9309-z

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  98 in total

Review 1.  Acute cardiac tamponade.

Authors:  David H Spodick
Journal:  N Engl J Med       Date:  2003-08-14       Impact factor: 91.245

2.  Cardiovascular magnetic resonance of imminent cardiac tamponade due to postpericardiotomy syndrome.

Authors:  Burkhard Sievers; Bodo Brandts; James C Moon; Dudley J Pennell; Hans-Joachim Trappe
Journal:  Int J Cardiol       Date:  2003-10       Impact factor: 4.164

3.  Effusive-constrictive pericarditis: the role of noninvasive imaging.

Authors:  Ana R Almeida; Luís R Lopes; Carlos Cotrim; Rita Miranda; Bruno Stuart; Hugo Vinhas; Manuel Carrageta; Hélder Pereira
Journal:  Rev Port Cardiol       Date:  2011-04       Impact factor: 1.374

4.  [Recurrent autoreactive pericardial effusion. Impact of an aetiological classification of pericarditis].

Authors:  B Maisch; K Karatolios; S Pankuweit
Journal:  Dtsch Med Wochenschr       Date:  2006-09-29       Impact factor: 0.628

5.  Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study.

Authors:  Dali Feng; James Glockner; Kyehun Kim; Matthew Martinez; Imran S Syed; Philip Araoz; Jerome Breen; Raul E Espinosa; Thoralf Sundt; Hartzell V Schaff; Jae K Oh
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

6.  Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.

Authors:  Leah Iles; Heinz Pfluger; Lisa Lefkovits; Michelle J Butler; Peter M Kistler; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2011-02-15       Impact factor: 24.094

7.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

8.  Cardiac magnetic resonance in the differentiation of neoplastic and nonneoplastic pericardial effusion.

Authors:  K N Boddy; M M Sleeper; C D Sammarco; C Weisse; S Ghods; H I Litt
Journal:  J Vet Intern Med       Date:  2011-07-22       Impact factor: 3.333

9.  Pericardial adaptations during chronic cardiac dilation in dogs.

Authors:  G L Freeman; M M LeWinter
Journal:  Circ Res       Date:  1984-03       Impact factor: 17.367

Review 10.  Cardiovascular magnetic resonance in pericardial diseases.

Authors:  Jan Bogaert; Marco Francone
Journal:  J Cardiovasc Magn Reson       Date:  2009-05-04       Impact factor: 5.364

View more
  14 in total

Review 1.  Immortalization protocols used in cell culture models of human breast morphogenesis.

Authors:  T Gudjonsson; R Villadsen; L Rønnov-Jessen; O W Petersen
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

Review 2.  New Cardiac Imaging Algorithms to Diagnose Constrictive Pericarditis Versus Restrictive Cardiomyopathy.

Authors:  Ahmad Mahmoud; Manish Bansal; Partho P Sengupta
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

3.  [Diagnostics and therapy of pericarditis and pericardial effusion].

Authors:  B Maisch; A D Ristić
Journal:  Herz       Date:  2014-11       Impact factor: 1.443

Review 4.  Autoimmune Pericarditis: Multimodality Imaging.

Authors:  Ghazaleh Goldar; Cassandra Garraud; Aaron A Sifuentes; Heba Wassif; Vardhmaan Jain; Allan L Klein
Journal:  Curr Cardiol Rep       Date:  2022-10-11       Impact factor: 3.955

5.  Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Jin Liu; Kana Fujikura; Hreedi Dev; Sadjad Riyahi; Jon Blumenfeld; Jiwon Kim; Hanna Rennert; Martin R Prince
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

Review 6.  The Role of Imaging with Cardiac Computed Tomography in Cardio-Oncology Patients.

Authors:  Barbora Pitekova; Sriram Ravi; Shimoli V Shah; Beata Mladosievicova; Stephen Heitner; Maros Ferencik
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

7.  Update of the Brazilian Guideline on Nuclear Cardiology - 2020.

Authors:  Luiz Eduardo Mastrocola; Barbara Juarez Amorim; João Vicente Vitola; Simone Cristina Soares Brandão; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima; Rafael Willain Lopes; William Azem Chalela; Lara Cristiane Terra Ferreira Carreira; José Roberto Nolasco de Araújo; Cláudio Tinoco Mesquita; José Claudio Meneghetti
Journal:  Arq Bras Cardiol       Date:  2020-02       Impact factor: 2.000

Review 8.  Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation.

Authors:  Malte Kircher; Constantin Lapa
Journal:  Curr Cardiovasc Imaging Rep       Date:  2017-02-10

Review 9.  Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins.

Authors:  B Maisch; P Alter
Journal:  Herz       Date:  2018-08       Impact factor: 1.443

10.  A Rare Case of Löffler "Pancarditis" Associated with Hypereosinophilic Syndrome.

Authors:  Makoto Yoshiji; Kensuke Matsumoto; Hiroshi Fujita; Keisuke Miwa; Hidekazu Tanaka; Masato Komatsu; Ken-Ichi Hirata
Journal:  Intern Med       Date:  2020-09-12       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.